- Home
- DCTH vs KRNY Comparison
DCTH vs KRNY Comparison
Compare DCTH & KRNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- KRNY
- Stock Information
- Founded
- DCTH 1988
- KRNY 1884
- Country
- DCTH United States
- KRNY United States
- Employees
- DCTH N/A
- KRNY N/A
- Industry
- DCTH Medical/Dental Instruments
- KRNY Savings Institutions
- Sector
- DCTH Health Care
- KRNY Finance
- Exchange
- DCTH Nasdaq
- KRNY Nasdaq
- Market Cap
- DCTH 398.2M
- KRNY 436.9M
- IPO Year
- DCTH N/A
- KRNY 2005
- Fundamental
- Price
- DCTH $14.31
- KRNY $7.23
- Analyst Decision
- DCTH Strong Buy
- KRNY Buy
- Analyst Count
- DCTH 4
- KRNY 2
- Target Price
- DCTH $22.25
- KRNY $7.75
- AVG Volume (30 Days)
- DCTH 411.6K
- KRNY 366.1K
- Earning Date
- DCTH 11-08-2024
- KRNY 01-30-2025
- Dividend Yield
- DCTH N/A
- KRNY 6.09%
- EPS Growth
- DCTH N/A
- KRNY N/A
- EPS
- DCTH N/A
- KRNY N/A
- Revenue
- DCTH $22,644,000.00
- KRNY $128,413,999.00
- Revenue This Year
- DCTH $1,605.13
- KRNY N/A
- Revenue Next Year
- DCTH $111.67
- KRNY $28.55
- P/E Ratio
- DCTH N/A
- KRNY N/A
- Revenue Growth
- DCTH 945.91
- KRNY N/A
- 52 Week Low
- DCTH $3.70
- KRNY $5.28
- 52 Week High
- DCTH $14.47
- KRNY $8.59
- Technical
- Relative Strength Index (RSI)
- DCTH 70.27
- KRNY 48.51
- Support Level
- DCTH $12.14
- KRNY $7.10
- Resistance Level
- DCTH $12.98
- KRNY $7.36
- Average True Range (ATR)
- DCTH 0.77
- KRNY 0.25
- MACD
- DCTH 0.16
- KRNY 0.04
- Stochastic Oscillator
- DCTH 95.12
- KRNY 80.00
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
About KRNY Kearny Financial Corp
Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. It is also heavily into secured and unsecured business and consumer loans. The bank's primary source of income is net interest income.